Zhejiang Orient Gene Biotech Co Ltd (688298) — Net Asset Quality Index
Zhejiang Orient Gene Biotech Co Ltd (688298) has a Net Asset Quality Index of 86.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥7.51 Billion minus total liabilities of CN¥1.01 Billion yields net assets of CN¥6.49 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Zhejiang Orient Gene Biotech Co Ltd to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Zhejiang Orient Gene Biotech Co Ltd Net Asset Quality Index Over Time (2016–2024)
This chart shows how Zhejiang Orient Gene Biotech Co Ltd's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the index stands at 86.5%, representing net assets of CN¥6.49 Billion against total assets of CN¥7.51 Billion CNY. Explore 688298 cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Zhejiang Orient Gene Biotech Co Ltd (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for Zhejiang Orient Gene Biotech Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 688298 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 83.9% | CN¥6.79 Billion | CN¥8.09 Billion | CN¥1.30 Billion | ▼ 0.0 pp |
| 2023 | 83.9% | CN¥7.55 Billion | CN¥9.00 Billion | CN¥1.45 Billion | ▲ +6.2 pp |
| 2022 | 77.8% | CN¥8.32 Billion | CN¥10.70 Billion | CN¥2.38 Billion | ▲ +1.0 pp |
| 2021 | 76.7% | CN¥6.89 Billion | CN¥8.98 Billion | CN¥2.09 Billion | ▲ +8.1 pp |
| 2020 | 68.6% | CN¥2.45 Billion | CN¥3.57 Billion | CN¥1.12 Billion | ▼ -1.7 pp |
| 2019 | 70.3% | CN¥254.13 Million | CN¥361.51 Million | CN¥107.38 Million | ▲ +8.7 pp |
| 2018 | 61.6% | CN¥208.03 Million | CN¥337.65 Million | CN¥129.62 Million | ▲ +8.3 pp |
| 2017 | 53.3% | CN¥138.12 Million | CN¥259.32 Million | CN¥121.20 Million | ▲ +12.3 pp |
| 2016 | 41.0% | CN¥98.72 Million | CN¥241.00 Million | CN¥142.28 Million | — |